{"chunk_id": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)__chunk_26", "source": "The-Pregnancy-and-Lactation-Labeling-Rule-(PDF---656KB)", "text": "regnancies is 2-4% and 15- \n20%, respectively. \n25 \n8.1 Pregnancy- Clinical Considerations \n • Clinical Considerations (five optional subheadings) \n– Disease-Associated Maternal and/or \nEmbryo/Fetal Risk \n– Dose Adjustments During Pregnancy and the \nPost-Partum Period \n– Maternal Adverse Reactions \n– Fetal/Neonatal Adverse Reactions \n– Labor or Delivery \nFDA/CDER/OND/ODEIV/DPMH \n8.1 Pregnancy – Clinical Considerations \nClinical Considerations \nDisease-Associated Maternal and/or Embryo/Fetal Risk"}